Lv6
2860 积分 2024-03-15 加入
Nanobodies® for veterinary health: multifunctional roles in diagnostics, therapeutics, and vaccines
3天前
已关闭
Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review
3天前
已完结
Nanobody-drug conjugates as versatile tools for improving therapeutic potential
3天前
已关闭
Theranostic application of 131I-labeled anti-glypican-3 antibody for targeted radioimmunotherapy in hepatocellular carcinoma
3天前
已关闭
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody–drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials
3天前
已完结
Treatments on the Horizon for Men with Advanced Prostate Cancer
3天前
已完结
Humanized synthetic nanobody library for antivenom development
3天前
已关闭
Nanobody-based targeted cancer therapy and immunotherapy: fear not the future
3天前
已完结
A rationally designed bispecific antibody targeting GPC3 and PD-L1 induces tumor-directed immune activation and cytotoxicity
3天前
已完结
Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3
3天前
已完结
皖公网安备34019202002308
